{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:38:26Z","timestamp":1792726706890,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["akdh.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1053\/j.akdh.2026.04.002","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:33:44Z","timestamp":1783024424000},"page":"143-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endocrine Hypertension in Children and Adults: Beyond Primary Aldosteronism"],"prefix":"10.1053","volume":"33","author":[{"given":"Stefanie","family":"Parisien-La Salle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athira","family":"Puthukara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6504-6008","authenticated-orcid":false,"given":"G. Chandra","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.akdh.2026.04.002_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/HYPERTENSIONAHA.124.24137","article-title":"Closing the gap in global disparities in hypertension control","volume":"82","author":"Mishra","year":"2025","journal-title":"Hypertension"},{"issue":"9","key":"10.1053\/j.akdh.2026.04.002_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033253","article-title":"Hypertension trends and disparities over 12 years in a large health system: leveraging the electronic health records","volume":"13","author":"Brush","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"38","key":"10.1053\/j.akdh.2026.04.002_bib3","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"10258","key":"10.1053\/j.akdh.2026.04.002_bib4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.akdh.2026.04.002_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40292-020-00415-9","article-title":"Practice recommendations for diagnosis and treatment of the most common forms of secondary hypertension","volume":"27","author":"Rossi","year":"2020","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"11","key":"10.1053\/j.akdh.2026.04.002_bib6","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/HYPERTENSIONAHA.124.22753","article-title":"Prevalence and risk factors for secondary hypertension in young adults","volume":"81","author":"de Freminville","year":"2024","journal-title":"Hypertension"},{"issue":"9981","key":"10.1053\/j.akdh.2026.04.002_bib7","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(14)61942-5","article-title":"Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial","volume":"385","author":"Azizi","year":"2015","journal-title":"Lancet"},{"key":"10.1053\/j.akdh.2026.04.002_bib8","article-title":"Secondary causes of hypertension in patients with resistant arterial hypertension","volume":"39","author":"Kvapil","year":"2021","journal-title":"J Hypertens"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.002_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional Study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1053\/j.akdh.2026.04.002_bib10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/jamapediatrics.2025.2206","article-title":"Global prevalence of hypertension in children and adolescents younger than 19 years: a systematic review and meta-analysis","volume":"179","author":"Ruan","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.002_bib11","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical Practice Guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1053\/j.akdh.2026.04.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ppedcard.2022.101581","article-title":"Overview of endocrine hypertension in children","volume":"68","author":"Metwalley","year":"2023","journal-title":"Prog Pediatr Cardiol"},{"issue":"10372","key":"10.1053\/j.akdh.2026.04.002_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(22)01330-7","article-title":"Congenital adrenal hyperplasia","volume":"401","author":"Auer","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.akdh.2026.04.002_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41371-017-0002-5","article-title":"Congenital adrenal hyperplasia causing hypertension: an illustrative review","volume":"32","author":"Hinz","year":"2018","journal-title":"J Hum Hypertens"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.002_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0889-8529(08)70019-7","article-title":"Steroid 11\u03b2-HYDROXYLASE deficiency and related disorders","volume":"30","author":"White","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.002_bib16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ejhg.2013.197","article-title":"Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations","volume":"22","author":"Menab\u00f2","year":"2014","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.002_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12020-016-1189-x","article-title":"Clinical perspectives in congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency","volume":"55","author":"Bulsari","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.002_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-2002-35389","article-title":"Congenital adrenal hyperplasia: 11beta-hydroxylase deficiency","volume":"20","author":"Peter","year":"2002","journal-title":"Semin Reprod Med"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.002_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/cen.15009","article-title":"Rare forms of congenital adrenal hyperplasia","volume":"101","author":"Gurpinar Tosun","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1053\/j.akdh.2026.04.002_bib20","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00467-021-05246-x","article-title":"Monogenic forms of low-renin hypertension: clinical and molecular insights","volume":"37","author":"Khandelwal","year":"2022","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.002_bib21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/cen.14677","article-title":"High prevalence of hypertension and target organ damage in patients with 11\u03b2-hydroxylase deficiency","volume":"96","author":"Sun","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1053\/j.akdh.2026.04.002_bib22","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-Hydroxylase deficiency: an Endocrine Society\u2217 Clinical Practice Guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.002_bib23","first-page":"1511","article-title":"Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia","volume":"86","author":"Quintos","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1053\/j.akdh.2026.04.002_bib24","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1210\/clinem\/dgad270","article-title":"Crinecerfont, a CRF1 receptor antagonist, lowers adrenal androgens in adolescents with congenital adrenal hyperplasia","volume":"108","author":"Newfield","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.002_bib25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s12020-024-03962-6","article-title":"17\u03b1 Hydroxylase\/17,20 lyase deficiency: clinical features and genetic insights from a large Turkey cohort","volume":"85","author":"Siklar","year":"2024","journal-title":"Endocrine"},{"issue":"Pt A","key":"10.1053\/j.akdh.2026.04.002_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jsbmb.2016.02.002","article-title":"Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic","volume":"165","author":"Auchus","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.002_bib27","doi-asserted-by":"crossref","first-page":"e1261","DOI":"10.1210\/clinem\/dgae773","article-title":"17\u03b1-Hydroxylase\/17,20-lyase deficiency (17-OHD): a meta-analysis of reported cases","volume":"110","author":"Willemsen","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.002_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000529158","article-title":"Presentation, diagnosis, and follow-up characteristics of 17\u03b1-Hydroxylase deficiency cases with exon 1-6 deletion (founder mutation) in the CYP17A1Gene: 20-year single-center experience","volume":"17","author":"Dundar","year":"2023","journal-title":"Sex Dev"},{"issue":"9","key":"10.1053\/j.akdh.2026.04.002_bib29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nrendo.2014.108","article-title":"Management of disorders of sex development","volume":"10","author":"Hiort","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1053\/j.akdh.2026.04.002_bib30","article-title":"Overview of monogenic forms of hypertension combined with hypokalemia","volume":"8","author":"Lu","year":"2020","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.002_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ecl.2019.08.003","article-title":"Low-renin hypertension","volume":"48","author":"Athimulam","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1053\/j.akdh.2026.04.002_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3349\/ymj.2022.0316","article-title":"Diagnosis and treatment of monogenic hypertension in children","volume":"64","author":"Park","year":"2023","journal-title":"Yonsei Med J"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.002_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1113\/jphysiol.2014.282871","article-title":"Cushing\u2019s syndrome: from physiological principles to diagnosis and clinical care","volume":"593","author":"Raff","year":"2015","journal-title":"J Physiol"},{"issue":"10418","key":"10.1053\/j.akdh.2026.04.002_bib34","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","article-title":"Cushing\u2019s syndrome","volume":"402","author":"Gadelha","year":"2023","journal-title":"Lancet"},{"issue":"7","key":"10.1053\/j.akdh.2026.04.002_bib35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing\u2019s syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1053\/j.akdh.2026.04.002_bib36","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/HJH.0000000000003252","article-title":"Diagnosis and management of hypertension in patients with Cushing\u2019s syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"40","author":"Fallo","year":"2022","journal-title":"J Hypertens"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.002_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing\u2019s syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"19","key":"10.1053\/j.akdh.2026.04.002_bib38","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/eht534","article-title":"Secondary arterial hypertension: when, who, and how to screen?","volume":"35","author":"Rimoldi","year":"2014","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1053\/j.akdh.2026.04.002_bib39","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s40618-024-02453-9","article-title":"Hypertension and Cushing\u2019s syndrome: hunt for the red flag","volume":"48","author":"Martino","year":"2025","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.002_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","article-title":"The hypertension of Cushing\u2019s syndrome: controversies in the pathophysiology and focus on cardiovascular complications","volume":"33","author":"Isidori","year":"2015","journal-title":"J Hypertens"},{"issue":"12","key":"10.1053\/j.akdh.2026.04.002_bib41","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.3390\/biomedicines11123115","article-title":"Epidemiology and management of hypertension and diabetes mellitus in patients with mild autonomous cortisol secretion: a review","volume":"11","author":"Araujo-Castro","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.002_bib42","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ecl.2019.08.005","article-title":"Hypertension and cardiovascular mortality in patients with cushing syndrome","volume":"48","author":"Nieman","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1053\/j.akdh.2026.04.002_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1329082","article-title":"Adrenal Cushing\u2019s syndrome in children","volume":"14","author":"Guarnotta","year":"2023","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1053\/j.akdh.2026.04.002_bib44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ecl.2018.02.008","article-title":"Cushing syndrome in pediatrics","volume":"47","author":"Lodish","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"10.1053\/j.akdh.2026.04.002_bib45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1053\/j.akdh.2026.04.002_bib46","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.akdh.2026.04.002_bib47","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1172\/JCI110565","article-title":"Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease","volume":"69","author":"Chrousos","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1053\/j.akdh.2026.04.002_bib48","series-title":"Endotext","article-title":"Primary generalized glucocorticoid resistance syndrome","author":"Kino","year":"2000"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.002_bib49","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1210\/jc.2008-0040","article-title":"Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder","volume":"93","author":"Charmandari","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.002_bib50","article-title":"The glucocorticoid resistance syndrome. Two cases of a novel pathogenic variant in the glucocorticoid receptor gene","volume":"2","author":"Mauri","year":"2024","journal-title":"JCEM Case Rep"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.002_bib51","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/jc.2009-1003","article-title":"Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1)","volume":"95","author":"McMahon","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.akdh.2026.04.002_bib52","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12967-022-03698-9","article-title":"Apparent mineralocorticoid excess: comprehensive overview of molecular genetics","volume":"20","author":"Lu Y ting","year":"2022","journal-title":"J Transl Med"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.002_bib53","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz315","article-title":"Classic and nonclassic apparent mineralocorticoid excess syndrome","volume":"105","author":"Carvajal","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.002_bib54","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1210\/clinem\/dgae663","article-title":"Progressive 11\u03b2-Hydroxysteroid dehydrogenase type 2 insufficiency as kidney function declines","volume":"110","author":"Uslar","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.002_bib55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tem.2023.12.003","article-title":"A clinical perspective on ectopic Cushing\u2019s syndrome","volume":"35","author":"Ragnarsson","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.akdh.2026.04.002_bib56","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1210\/jc.2003-030138","article-title":"Hypertension and the cortisol-cortisone shuttle","volume":"88","author":"Quinkler","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.002_bib57","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1590\/S0004-27302004000500015","article-title":"Apparent mineralocorticoid excess syndrome: an overview","volume":"48","author":"Palermo","year":"2004","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.002_bib58","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2265.1996.00853.x","article-title":"Urinary free cortisone and the assessment of 11\u03b2-hydroxysteroid dehydrogenase activity in man","volume":"45","author":"Palermo","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1053\/j.akdh.2026.04.002_bib59","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac105","article-title":"Systematic review: incidence of pheochromocytoma and paraganglioma over 70 years","volume":"6","author":"Al Subhi","year":"2022","journal-title":"J Endocr Soc"},{"key":"10.1053\/j.akdh.2026.04.002_bib60","doi-asserted-by":"crossref","DOI":"10.1186\/s40200-016-0226-x","article-title":"Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms","volume":"15","author":"Pourian","year":"2015","journal-title":"J Diabetes Metab Disord"},{"issue":"2","key":"10.1053\/j.akdh.2026.04.002_bib61","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ecl.2011.02.002","article-title":"Hypertension in pheochromocytoma: characteristics and treatment","volume":"40","author":"Zuber","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"8","key":"10.1053\/j.akdh.2026.04.002_bib62","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"issue":"10","key":"10.1053\/j.akdh.2026.04.002_bib63","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s12094-021-02622-9","article-title":"Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas","volume":"23","author":"Garcia-Carbonero","year":"2021","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.002_bib64","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1210\/clinem\/dgad401","article-title":"Pheochromocytomas most commonly present as adrenal incidentalomas: a large tertiary Center experience","volume":"109","author":"Aggarwal","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.akdh.2026.04.002_bib65","first-page":"69","article-title":"Metabologenomics of phaeochromocytoma and paraganglioma: an integrated approach for personalised biochemical and genetic testing","volume":"38","author":"Eisenhofer","year":"2017","journal-title":"Clin Biochem Rev"},{"issue":"2","key":"10.1053\/j.akdh.2026.04.002_bib66","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1053\/j.akdh.2026.04.002_bib67","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fped.2017.00155","article-title":"Review of pediatric pheochromocytoma and paraganglioma","volume":"5","author":"Bholah","year":"2017","journal-title":"Front Pediatr"},{"issue":"6","key":"10.1053\/j.akdh.2026.04.002_bib68","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.002_bib69","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1097\/JS9.0000000000000390","article-title":"Preoperative \u03b1-blockade versus no blockade for pheochromocytoma\u2013paraganglioma patients undergoing surgery: a systematic review and updated meta-analysis","volume":"109","author":"Wang","year":"2023","journal-title":"Int J Surg"},{"issue":"11","key":"10.1053\/j.akdh.2026.04.002_bib70","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/jch.12598","article-title":"Prevalence of liddle syndrome among young hypertension patients of undetermined cause in a Chinese population","volume":"17","author":"Wang","year":"2015","journal-title":"J Clin Hypertens"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.002_bib71","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/HJH.0000000000001556","article-title":"Analysis of the genes involved in Mendelian forms of low-renin hypertension in Chinese early-onset hypertensive patients","volume":"36","author":"Liu","year":"2018","journal-title":"J Hypertens"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.002_bib72","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/ijms19030812","article-title":"Liddle syndrome: review of the literature and description of a new case","volume":"19","author":"Tetti","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.002_bib73","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0092-8674(94)90250-X","article-title":"Liddle\u2019s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel","volume":"79","author":"Shimkets","year":"1994","journal-title":"Cell"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.002_bib74","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.4102\/ajlm.v12i1.1998","article-title":"Neonatal presentation of a patient with liddle syndrome, South Africa","volume":"12","author":"Steyn","year":"2023","journal-title":"Afr J Lab Med"},{"key":"10.1053\/j.akdh.2026.04.002_bib75","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/IBPC.S188869","article-title":"Liddle\u2019s syndrome mechanisms, diagnosis and management","volume":"12","author":"Enslow","year":"2019","journal-title":"Integr Blood Press Control"},{"issue":"11","key":"10.1053\/j.akdh.2026.04.002_bib76","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00467-014-2956-7","article-title":"Gordon syndrome: a continuing story","volume":"30","author":"O\u2019Shaughnessy","year":"2015","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"10","key":"10.1053\/j.akdh.2026.04.002_bib77","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3390\/genes14101878","article-title":"A Spanish family with Gordon syndrome due to a variant in the acidic motif of WNK1","volume":"14","author":"Peces","year":"2023","journal-title":"Genes"},{"key":"10.1053\/j.akdh.2026.04.002_bib78","series-title":"GeneReviews","article-title":"Pseudohypoaldosteronism type II","author":"Ellison","year":"1993"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.002_bib79","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imj.1970.19.4.287","article-title":"Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction","volume":"19","author":"Gordon","year":"1970","journal-title":"Australas Ann Med"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.002_bib80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.21037\/gs.2019.10.21","article-title":"Primary hyperparathyroidism and hypertension","volume":"9","author":"Fisher","year":"2020","journal-title":"Gland Surg"},{"key":"10.1053\/j.akdh.2026.04.002_bib81","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijcard.2016.11.080","article-title":"Primary hyperparathyroidism predicts hypertension: results from the National inpatient Sample","volume":"227","author":"Kalla","year":"2017","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1053\/j.akdh.2026.04.002_bib82","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1507\/endocrj.EJ15-0392","article-title":"Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients","volume":"63","author":"Yener Ozturk","year":"2016","journal-title":"Endocr J"},{"key":"10.1053\/j.akdh.2026.04.002_bib83","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fendo.2019.00482","article-title":"Hypertension in thyroid disorders","volume":"10","author":"Berta","year":"2019","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.002_bib84","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1020798430884","article-title":"Pathogenesis and prevalence of hypertension in acromegaly","volume":"4","author":"Bondanelli","year":"2001","journal-title":"Pituitary"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813926000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813926000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:00:03Z","timestamp":1792724403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813926000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2949813926000662"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2026.04.002","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine Hypertension in Children and Adults: Beyond Primary Aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2026.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}